ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3254

A Clinical Risk Score to Predict Functional Disability at 1 Year in an Early Rheumatoid Arthritis Inception Cohort

Caroline Kronisch1,2, David Mclernon3, James Dale4, Caron Paterson4, Stuart H. Ralston5, David M. Reid6, Ann Tierney4, John Harvie7, Neil McKay8, Hilary E. Wilson9, Robin Munro10, Sarah Saunders11, Ruth Richmond12, Derek Baxter13, Mike McMahon14, Vinod Kumar15, John McLaren16, Stefan Siebert4, Iain B. McInnes17, Duncan Porter4, Gary J. Macfarlane2 and Neil Basu2, 1Department of Rheumatology, Cantonal Hospital Fribourg, Fribourg, Switzerland, 2Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 3Musculoskeletal Research Collaboration (Medical Statistics Team), University of Aberdeen, Aberdeen, United Kingdom, 4Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 5Centre for Genomic and Experimental Medicine, Western General Hospital, Edinburgh, United Kingdom, 6Musculoskeletal Research Collaboration (Medicine & Therapeutics), University of Aberdeen, Aberdeen, United Kingdom, 7Department of Rheumatology, Raigmore Hospital, Inverness, United Kingdom, 8Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom, 9Department of Rheumatology, Stobhill General Hospital, Glasgow, United Kingdom, 10Department of Rheumatology, Wishaw General Hospital, Lanarkshire, United Kingdom, 11Centre of Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, United Kingdom, 12Department of Rheumatology, Borders General Hospital, Melrose, United Kingdom, 13Department of Rheumatology, University Hospital Ayr, Ayr, United Kingdom, 14Department of Rheumatology, Dumfries & Galloway Royal Infirmary, Dumfries, United Kingdom, 15Department of Rheumatology, Ninewells Hospital, Dundee, United Kingdom, 16Department of Rheumatology, Whyteman Brae Hospital, Fife, United Kingdom, 17Immunology, Infection and Inflammation, University of Glasgow, Glasgow, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Health Assessment Questionnaire, Prognostic factors and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 11, 2015

Title: Rheumatoid Arthritis - Clinical Aspects VII: Disease Activity and Updates in Measurement

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: When diagnosed with rheumatoid arthritis (RA),
patients are especially concerned by the prospect of disability. Predictors of
future disability may inform early decision making. Previous studies have
sought to identify such predictors, but have been limited to the evaluation of
traditional biomedical measures within historical cohorts. This study aimed to
evaluate both psychosocial and biomedical factors, within a contemporary RA cohort,
in order to identify baseline predictors of significant disability at 1 year. Subsequently,
we aimed to develop a clinically useful tool which may support early patient
education and decision making.

Methods: Analysis used data from the Scottish Early Rheumatoid
Arthritis (SERA) inception cohort, an ongoing prospective multicentre study
which began recruitment in September 2011. A forward stepwise multivariable
logistic regression model was developed. Exposures were putative psychosocial
(e.g. work ability, depression, and anxiety) and biomedical (e.g. DAS28-CRP
score, neutrophil count and morning stiffness) baseline predictor variables.
The outcome was high functional disability (defined as a Health Assessment
Questionnaire [HAQ] score >1) at 1 year. The ability of the model to
correctly discriminate between patients at low and high risk of the outcome was
assessed using the c-statistic. Finally, a clinical prediction score was
created based on the coefficients of the predictors determined by the logistic
regression model. Each score was translated into a probability of reporting a
high HAQ score at 1 year. As a method of external validation, the score was
tested using SERA patient data which had been newly acquired since the initial
analysis.

Results: Of 578 participants (64.5% female), 80.6% (466/578)
fulfilled the 2010 ACR/EULAR classification criteria and 36.7% (212) exhibited
high functional disability at 1 year with a HAQ >1. Independent predictors
were baseline high HAQ score (OR 2.67; 95%CI 1.98 – 3.59), depression (2.52;
1.18 – 5.37), anxiety (2.37; 1.33 – 4.21), being in paid employment with
absenteeism during the last seven days (1.19; 0.63 – 2.23), not in paid
employment (2.36; 1.38 – 4.03) and obesity (1.61; 1.04 – 2.50). The good
discriminative performance of the model was evidenced by a c-statistic of 0.78.
The clinical prediction score (Table 1) ranged from 0 – 26 and had a
good discriminative performance in both the original (c-statistic 0.78) and
validation data sets (c-statistic 0.78).

Conclusion: In the context of modern treatment paradigms,
predictors of 1 year disability appear to be dominated by psychosocial rather
than more traditional biomedical measures. Such information may aid both
patients and physicians during initial management planning and alludes to the
potential benefit of early non-pharmacological interventions targeting key
psychosocial factors such as mental health and work disability.


Disclosure: C. Kronisch, None; D. Mclernon, None; J. Dale, Pfizer Inc, 2,BMS, 2,Pfizer Inc, 8,Abbvie, 8,Janssen Pharmaceutica Product, L.P., 8; C. Paterson, None; S. H. Ralston, None; D. M. Reid, None; A. Tierney, None; J. Harvie, None; N. McKay, None; H. E. Wilson, None; R. Munro, None; S. Saunders, None; R. Richmond, None; D. Baxter, None; M. McMahon, None; V. Kumar, None; J. McLaren, None; S. Siebert, None; I. B. McInnes, Pfizer Inc, 2,Pfizer Inc, 5; D. Porter, Pfizer Inc, 2,Pfizer Inc, 5; G. J. Macfarlane, Pfizer Inc;, 2,Pfizer Inc, 9,AbbVie, 2; N. Basu, Pfizer Inc, 2,Pfizer Inc, 5,Roche Pharmaceuticals, 8.

To cite this abstract in AMA style:

Kronisch C, Mclernon D, Dale J, Paterson C, Ralston SH, Reid DM, Tierney A, Harvie J, McKay N, Wilson HE, Munro R, Saunders S, Richmond R, Baxter D, McMahon M, Kumar V, McLaren J, Siebert S, McInnes IB, Porter D, Macfarlane GJ, Basu N. A Clinical Risk Score to Predict Functional Disability at 1 Year in an Early Rheumatoid Arthritis Inception Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-clinical-risk-score-to-predict-functional-disability-at-1-year-in-an-early-rheumatoid-arthritis-inception-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-clinical-risk-score-to-predict-functional-disability-at-1-year-in-an-early-rheumatoid-arthritis-inception-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology